deltatrials
Terminated PHASE4 INTERVENTIONAL NCT00152308

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions

Sponsor: Translumina GmbH

Conditions Coronary Disease
Interventions 1% rapamycin-eluting YUKONdes PEARL-stent 2% rapamycin-eluting YUKONdes PEARL-stent YUKONdes PEARL-stent coated with placebo (ethanol)
Updated 6 times since 2017 Last updated: Oct 6, 2020 Started: Dec 31, 2004 Completion: Feb 28, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow enrolement

Other Coronary Disease trials with similar outcome

Browse all Coronary Disease trials

A PHASE4 clinical study on Coronary Disease, this trial is terminated or withdrawn. The trial is conducted by Translumina GmbH and has accumulated 6 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Nov 2020 · 46 months · monthly snapshotUnknown Status~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE4

    Status: Unknown Status → Terminated

▶ Show 1 earlier version

  1. Jan 2017 — Nov 2020 [monthly]

    Unknown Status PHASE4

    First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Translumina GmbH
Data source: Translumina GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations